Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study, International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press,
DOI: 10.2147/copd.s159732.
You can read the full text:

Open access logo


The following have contributed to this page